Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Collaboration Unravels Novel Mechanism for Neurological Disorder

Published: Saturday, April 26, 2014
Last Updated: Thursday, May 01, 2014
Bookmark and Share
The novel gene (CLP1) associated with a neurological disorder affecting both the peripheral and central nervous systems.

A team of international scientists led by Baylor College of Medicine has shown that disturbance of a very basic biological process, tRNA biogenesis, can result in cell death of neural progenitor cells. This leads to abnormal brain development and a small head circumference as well as dysfunction of peripheral nerves.

The study is published in the current issue of the journal Cell

“This is the first human disorder associated with the gene CLP1,” said Dr. Ender Karaca, post-doctoral associate in the department of molecular and human genetics at Baylor.

Significant find
The gene find is significant because CLP1 has a role in RNA processing and has important implications for genomic approaches to Mendelian disease and for our understanding of human biology and brain development, Karaca said.

Karaca’s work with families of this rare disorder began many years ago during his residency training as a clinical geneticist in Turkey.

A chance meeting with Dr. James R. Lupski, the Cullen Professor and Vice Chair of Molecular and Human Genetics and professor of pediatrics at Baylor, at a medical meeting in Istanbul, Turkey would lead to Karaca’s recruitment as a trainee in Lupski’s lab where the research took off and eventually the team unveiled new clues about the genetic malfunction that may be causing the disorder in these families.

Lupski leads the Center for Mendelian Genomics at Baylor, a joint program with the Johns Hopkins University School of Medicine that is co-funded by the National Human Genome Research Institute and The National Heart, Lung, and Blood Institute. The Center is focused on advancing research of the cause of rare, single-gene diseases usually called Mendelian disorders.

Mutations in two unrelated families
Using whole exome sequencing (a next generation test to analyze the exons or coding regions of thousands of genes simultaneously) conducted at the Baylor College of Medicine Human Genome Sequencing Center, the researchers identifiedCLP1 mutations in two unrelated families with the disorder.

The two families had distinct facial dysmorphic features that led Karaca to identify the gene in three additional families with very similar features.

“With the first families, we had no idea what gene might be causing this disorder, so we did a genome analysis and a good candidate gene screen came in with CLP1,” said Karaca.

Based on his clinical knowledge of brain formation, he identified three additional families with very similar clinical and radiological features as the two families with confirmed CLP1 mutations.

“This time we sequenced the families for this specific CLP1 gene mutation and all had it,” said Karaca.

Taking a closer look
But the identification of the mutation also brought new questions for the researchers that caused them to dig deeper into the gene.

“In all four families there were a total of eight people affected and now the problem is they all have the same gene mutated but one variant,” said Lupski, the corresponding author of the report. “Ideally, we would have four families with the same gene but multiple types of mutations. This is sort of a polymorphism (a variation of unknown significance), so we started to think about other ways to obtain experimental evidence to support that this mutation was causative for the disease by doing functional studies on the variant.”

Another chance encounter between Dr. Richard Gibbs, director of the Human Genome Sequencing Center at Baylor, and Dr. Josef Penninger, scientific director of IMBA, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences in Vienna, who had a lot of interest already in CLP1 – and a mouse model to test new experiments with the gene – led to further discoveries of the importance of this gene.

“Penninger’s mouse model had shown some of the similarities of the patients in the study with regard to the peripheral nervous system, but they had not identified brain malformation or small heads,” said Lupski. “But when we showed them our patient data, they went back very carefully and looked, and indeed showed these same features.”

It is remarkable that we used patient clinical information to enhance research and help guide experimental investigations then conducted in Vienna in their mouse model, said Lupski.

Model characterizes disease
Penninger’s team then could experimentally manipulate their animal model and further characterize this rare disease. “They answered key questions, and it became clear that this is not just a brain disease or a peripheral nerve disease; in fact, this spoke to some kind of neural stem cell progenitor problem,” said Lupski. “The Vienna team of Dr. Javier Martinez, also a co-corresponding author on the study, could actually show that mutations in CLP1 affect tRNA biogenesis and that CLP1 mutant brain stem cells become more apoptotic (invoking cell death). The idea of neural progenitor or stem cell susceptibility to cell death may be a conceptual leap in the mechanism for a host of neurological disorders,” said Lupski.

The invocation of cell death in this disorder would explain the clinical feature, the small heads caused by loss of nerve cells in the brain, the team found.

“This is a new way of thinking in the neurobiology field,” said Lupski. “Basically it is a mutation that makes potential stem cells, or precursor cells, susceptible to apoptotic cell death pathways. So we have to start thinking about lots of diseases that might fall into this category, for example ALS (Lou Gehrig’s disease).”

“As the Baylor-Johns Hopkins Center for Mendelian Genomics enters year three of our four year grant, we have found new learning opportunities with each phenotype,” said Shalini Jhangiani, senior project manager in the Human Genome Sequencing Center and a co-author on the study. “To date we have over 350 phenotypes enrolled in our study with over 3,200 patient samples having undergone exome sequencing.  The CLP1 story has raised expectations for future collaborative studies.”

Baylor and the Institute of Molecular Biotechnology of the Austrian Academy of Sciences collaborated with a large team of scientists from around the world including: Rockefeller University in New York; Massachusetts General Hospital in Boston; Gaziantep Children’s Hospital, Bezmialem University in Istanbul, Cerrahpasa Medical School of Instanbul University, and Instanbul Medeniyet University, all in Turkey; University Medical Center Hamburg-Eppendorf in Germany and the Medical University of Vienna.

Funding for this work was provided by: the National Institutes of Neurological Disorders and Stroke (R01NS058529, K23NS078056); the National Human Genome Research Institute (U54HG006542); the Astellas Foundation for Research on Metabolic Disorders; The Mochida Memorial Foundation for Medical and Pharmaceutical Research; Deutsche Forschungsgemeinschaft; Institute of Molecular Biotechnology of the Austrian Academy of Sciences and the European Research Council.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Baylor, DNAnexus Collaborate
Partnership sets out to develop HgV, a new iteration of HGSC's Mercury, a BCM-developed data processing and variant calling pipeline for analyzing and annotating next-generation sequencing data in research and clinical contexts.
Tuesday, June 23, 2015
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Tuesday, May 26, 2015
Role of Cancer Stem Cells in Chemo-Resistance
'Wound response' of cancer stem cells may explain chemo-resistance in bladder cancer.
Friday, December 05, 2014
Massimo Pietropaolo Named McNair Scholar at Baylor
World renowned physician-scientist in type 1 diabetes research, Dr. Massimo Pietropaolo, has been named McNair Scholar at Baylor College of Medicine.
Wednesday, October 29, 2014
Clinical Integration of NGS
Experts provide much-needed policy analysis for clinical integration of next generation sequencing.
Tuesday, September 23, 2014
$3M NIH Grant Enables Baylor International HIV/AIDS Program
Researchers to study genetic differences of disease in sub-Saharan African children.
Wednesday, February 19, 2014
Baylor College of Medicine, Berry Genomics Co. Seek to Improve on Prenatal Genetic Tests
Teams aim to improve prenatal genetic testing by combining BCM’s expertise in using microarrays for DNA analysis and Berry’s non-invasive technology evaluating fetal DNA in maternal plasma.
Monday, January 07, 2013
Microarray Analysis Improves Prenatal Diagnosis
A "chip" or array that can quickly detect disorders such as Down syndrome, or other diseases associated with chromosomal abnormalities, has proved an effective tool in prenatal diagnosis in 300 cases, as reported by Baylor College of Medicine.
Tuesday, November 29, 2011
Experimental Drug Targets Chemo-Resistant Breast Cancer Stem Cells
The cells that remain after treatment that could potentially refuel tumor growth, researchers say.
Monday, December 14, 2009
Protein 'Tubules' Free Avian Flu Virus from Immune Recognition
Two domains or portions of the protein NS1 combine to form tiny tubules where double-stranded RNA is hidden from the immune system, researchers say.
Friday, November 07, 2008
High Throughput Imaging Speeds Analysis of Hormone Receptors
A new high throughput microscopy technique enabled researchers at Baylor College of Medicine to analyze thousands of individual cells expressing androgen receptor.
Monday, November 03, 2008
Lack of Fragile X, Related Gene Disrupts Sleep
Deficiency of the FMR1 gene and a similar gene called FXR2 could account for sleep problems associated with inherited mental impairment.
Friday, June 27, 2008
Ronin Provides Alternate Pathway to Pristine Embryonic Stem Cells
The protein Ronin maintains embryonic stem cells in their undifferentiated state and plays roles in genesis of embryos and their development, researchers say.
Friday, June 27, 2008
Nature Mixes, Matches Genes to Keep Nerve Cells Straight
BCM researchers report that nature has to mix and match thousands of genes to generate the myriad types of neurons needed to assemble the brain and nervous system.
Thursday, June 12, 2008
Findings Indicate How Gene Transcription is Controlled in Embryonic Stem Cells
In a report that appears in the journal Nature Cell Biology, BCM researchers explain that association determines fate in embryonic stem cells.
Monday, May 05, 2008
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos